Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven D Chang

Showing results (301-310 of 311) with videos related to

Pageof 32
Sort By:
Neuro-Oncology Advances|June 22, 2026
A WEb-Accessible comprehensiVE platform for automatic vestibular schwannoma segmentation and longitudinal volumetric trackingRiya Prashad, Gregory Szalkowski, Jen-Yeu Wang, et al.
Neurosurgery Practice|October 30, 2025
Efficacy and Safety of CyberKnife Stereotactic Radiosurgery for Occipital Condyle MetastasisDavid J Park, Harini Voruganti, Shreyas Annagiri, et al.
Journal of Neurosurgery|October 31, 2025
Treatment outcomes for hypoglossal schwannomas: insights from a single-institution experience and literature reviewAhed H Kattaa, David J Park, Amit R Persad, et al.
Brain Sciences|February 26, 2025
Use of Carbon Fiber Implants to Improve the Safety and Efficacy of Radiation Therapy for Spine Tumor PatientsFred C Lam, Santosh Guru, Deyaldeen AbuReesh, et al.
International Journal of Radiation Oncology, Biology, Physics|June 8, 2017
Phase 1/2 Trial of 5-Fraction Stereotactic Radiosurgery With 5-mm Margins With Concurrent and Adjuvant Temozolomide in Newly Diagnosed Supratentorial Glioblastoma: Health-Related Quality of Life ResultsErqi L Pollom, Dylann Fujimoto, Jacob Wynne, et al.
Practical Radiation Oncology|February 3, 2023
Patterns of Progression in Patients With Newly Diagnosed Glioblastoma Treated With 5-mm Margins in a Phase 1/2 Trial of 5-Fraction Stereotactic Radiosurgery With Concurrent and Adjuvant TemozolomideMaria G Mendoza, Melissa Azoulay, Steven D Chang, et al.
Neuro-Oncology|February 1, 2020
A phase I/II trial of 5-fraction stereotactic radiosurgery with 5-mm margins with concurrent temozolomide in newly diagnosed glioblastoma: primary outcomesMelissa Azoulay, Steven D Chang, Iris C Gibbs, et al.
World Neurosurgery|June 2, 2023
Impact of Cochlear Dose on Hearing Preservation Following Stereotactic Radiosurgery in Treatment of Vestibular Schwannomas: A Multi-Center StudySteven D Chang, Alexander Muacevic, Andrea L Klein, et al.
Neuro-Oncology|February 14, 2025
Local tumor control and neurological outcomes after surgery for spinal hemangioblastomas in sporadic and Von-Hippel-Lindau Disease: A multicenter studyJohannes Wach, Alim Emre Basaran, Martin Vychopen, et al.
Acta Neuropathologica Communications|December 11, 2025
Prognostic relevance of MIB-1 labeling index in VHL-associated and sporadic spinal hemangioblastomas: a subgroup analysis from a multicentric studyJohannes Wach, Alim Emre Basaran, Obada T Alhalabi, et al.
Pageof 32

Showing results (301-310 of 311) with videos related to

Sort By:
Pageof 32
Neuro-Oncology Advances|June 22, 2026
A WEb-Accessible comprehensiVE platform for automatic vestibular schwannoma segmentation and longitudinal volumetric trackingRiya Prashad, Gregory Szalkowski, Jen-Yeu Wang, et al.
Neurosurgery Practice|October 30, 2025
Efficacy and Safety of CyberKnife Stereotactic Radiosurgery for Occipital Condyle MetastasisDavid J Park, Harini Voruganti, Shreyas Annagiri, et al.
Journal of Neurosurgery|October 31, 2025
Treatment outcomes for hypoglossal schwannomas: insights from a single-institution experience and literature reviewAhed H Kattaa, David J Park, Amit R Persad, et al.
Brain Sciences|February 26, 2025
Use of Carbon Fiber Implants to Improve the Safety and Efficacy of Radiation Therapy for Spine Tumor PatientsFred C Lam, Santosh Guru, Deyaldeen AbuReesh, et al.
International Journal of Radiation Oncology, Biology, Physics|June 8, 2017
Phase 1/2 Trial of 5-Fraction Stereotactic Radiosurgery With 5-mm Margins With Concurrent and Adjuvant Temozolomide in Newly Diagnosed Supratentorial Glioblastoma: Health-Related Quality of Life ResultsErqi L Pollom, Dylann Fujimoto, Jacob Wynne, et al.
Practical Radiation Oncology|February 3, 2023
Patterns of Progression in Patients With Newly Diagnosed Glioblastoma Treated With 5-mm Margins in a Phase 1/2 Trial of 5-Fraction Stereotactic Radiosurgery With Concurrent and Adjuvant TemozolomideMaria G Mendoza, Melissa Azoulay, Steven D Chang, et al.
Neuro-Oncology|February 1, 2020
A phase I/II trial of 5-fraction stereotactic radiosurgery with 5-mm margins with concurrent temozolomide in newly diagnosed glioblastoma: primary outcomesMelissa Azoulay, Steven D Chang, Iris C Gibbs, et al.
World Neurosurgery|June 2, 2023
Impact of Cochlear Dose on Hearing Preservation Following Stereotactic Radiosurgery in Treatment of Vestibular Schwannomas: A Multi-Center StudySteven D Chang, Alexander Muacevic, Andrea L Klein, et al.
Neuro-Oncology|February 14, 2025
Local tumor control and neurological outcomes after surgery for spinal hemangioblastomas in sporadic and Von-Hippel-Lindau Disease: A multicenter studyJohannes Wach, Alim Emre Basaran, Martin Vychopen, et al.
Acta Neuropathologica Communications|December 11, 2025
Prognostic relevance of MIB-1 labeling index in VHL-associated and sporadic spinal hemangioblastomas: a subgroup analysis from a multicentric studyJohannes Wach, Alim Emre Basaran, Obada T Alhalabi, et al.
Pageof 32